ABSTRACT
INTRODUCTION
Squamous cell carcinoma (SCC) is the most frequent primary malignant tumor of the temporal bone, but the incidence is as rare as <0.2% of all tumors of the head and neck. [1] It is a rare, but threateningly aggressive, tumor with poor prognosis. Many publications have tried to evaluate survival in this aggressive disease, but patient numbers are limited (ranging from 10 to 39 patients, with most <30 patients), and surveillance periods are too long (ranging from 10 to 37 years, with most >15 years), possibly due to the rarity of this disease. [1] [2] [3] [4] [5] [6] [7] [8] [9] The quality of imaging studies (Computed tomography (CT) and magnetic resonance imaging (MRI)) has improved dramatically over time, and the accuracy of diagnosis of this disease is influenced by the quality of imaging. Similar reports contain many patients, but they are multi-institutional retrospective studies, with the surgical procedure and the surgeon different at each institution and surveillance periods are too long (>20 years). [10, 11] By chance, we had experience with 16 cases of primary SCC of the temporal bone over 6 years (from 2001 to 2006). Because it was a brief surveillance period, the qualities of the imaging studies were similar and the same surgeon performed all surgical procedures. The University of Pittsburgh staging system [12] is most common classification tool for temporal bone SCC, and we followed the modified version of this classification for these patients [1] .
Although many previous reports conclude that long-term prognosis of temporal bone SCC depends mainly on staging and primary treatment [1, 4, 5] , there is no universally accepted staging system for temporal bone SCC. Due to the limited database for this tumor type, it has been difficult to determine any correlation between the clinical conditions, clinical symptoms and the extent of the lesion, and prognosis. In the present study, we try to evaluate the prognostic factors associated with the survival rate for SCC of the temporal bone.
MATERIALS AND METHODS
A retrospective case review was performed on all patients receiving treatment of SCC of the external auditory canal or middle ear at Kanazawa University Hospital (Kanazawa, Japan) from 2001 to 2006. The observation duration for survival was defined as ≥ 30 months after diagnosis. Clinical symptoms before treatment were identified based on patient medical records. The extent of the lesion was estimated for all patients through imaging study and physical examination findings. Computed tomography and MRI were routinely conducted and positron emission tomography (PET) was carried out in some cases. Bone invasion and soft tissue involvement were determined by CT scan and MRI, respectively. Regional lymph node swelling and distant metastases were distinguished by PET scan. Tumors of the external auditory canal (EAC) and middle ear (ME) were staged according to the University of Pittsburgh staging system (Moody's modified) for malignancies of the EAC (for definitions, see Table 1 ). [1, 12] All tumors of the ME were classified into T4 stage because tumors were eroding deep parts of the temporal bone.
The surgical resection we performed most often was lateral temporal bone resection (LTBR) (n=10). In cases of LTBR, the bony and cartilaginous portions of the EAC, including the anterior bony EAC, were removed en bloc. All surgical procedures were performed by the same surgeon (Ito.M). Lateral temporal bone resection was performed combined with radiation therapy for the tumors that remained lateral to the tympanic membrane. All patients with T2 and T3 diseases received LTBR. Lateral temporal bone resection was also performed for some patients with T1 and T4 disease; CT, MRI, and/or PET were routinely carried out every 6 months for up to 3 years after treatment. Because scar tissue after surgery or irradiation was often hard to differentiate from recurrent SCC, we distinguished them by using size enlargement of a space-occupying lesion. Clinical outcomes included the occurrence and timing of any recurrence (local, regional lymph node, or distant metastasis), the last follow-up date, and death. Disease-specific survival (DSS) rates were determined using the Kaplan-Meier method and the log-rank test was applied to compare survival outcomes.
The correlation of clinical symptoms before treatment and T staging in the Pittsburgh classification with DSS was analyzed statistically. P-values <0.05 were considered statistically significant.
RESULTS
The medical records for a total of 16 patients with the primary SCC of the EAC (n=13) and ME (n=3) were reviewed retrospectively ( Table 2 ). There were 7 males and 9 females, ranging in age from 41 to 83 years, and the mean age at first visit for the population was 64 ± 13.8 years. The distribution of T stages for primary tumors was T1: 3, T2: 2, T3: 3, and T4: 8. All ME diseases (Nos.9, 14, 15) were classified into T4 stage in the present study. One patient (No.12) in the T4 group had regional lymph node involvement. The most common presenting symptoms were otorrhea (15 patients:
93.7%), otalgia (12 patients: 75.0%), and hearing disturbance (10 patients: 62.5%).
Disease-specific survival was not influenced by whether otalgia or hearing disturbance (HD) were present at the time of the diagnosis (Figures 1 and 2 ). Facial nerve paralysis was found in 3 patients (Nos.14, 15 and 16) and these three patients were classified into T4 because of extensive bone involvement with Pittsburgh staging system; i.e. dural involvement and major vessels invasion, and their prognoses were quite poor, with survival times not longer than 12 months. In addition to the facial nerve paralysis, bone destruction of the fallopian canal was detected in three patients who did not show facial paralysis (No. 8 in T3 and Nos. 12 and 13 in T4). We performed LTBR for these three patients, one male patient (No.8) received additional facial nerve resection and other two female patients (No.12 and 13) refused resection of the facial nerve, and surgical margins of these three patients were positive. Then these patients received post-operative radiation therapy. They showed facial paralysis at the time of local recurrences and their survival times were not longer than 28 months.
Within these three patients, one patient (No. 8 in T3) represented tumor eroding the osseous external auditory canal (full-thickness) and the fallopian canal then we performed LTBR. Unfortunately the pathological diagnosis after surgery showed tumor invasion into the mastoid and the deep temporal bone. One patient (No. 12 in T4)
represented tumor eroding the jugular foramen and we recommended STBR but she refused resection of the facial nerve and STBR. It might be better to choose STBR instead of LTBR for these two patients. Another one patient (No. 13) showed carotid canal bone involvement so that we did not recommend surgery but patient asked us gross tumor removal before radiotherapy.
In contrast, there were other four advanced stage patients (Nos. 6, 7 in T3 and Nos. 10, 11 in T4) without extensive bone destruction of the deep temporal bone. They received complete LTBR and surgical margins were negative. The prognoses of these four patients were quite well, no disease over 32 months. Another one patient in ME tumor (No. 9 in T4) received STBR and her prognosis was well. Among the total 16 patients, 7 patients died of disease. Six patients underwent insufficient / no surgery and all of them died of disease. On the other hand, only one patient died of disease among 10 patients who underwent total tumor removal ( Figure 6, p<0.01) . Resectability of the tumor was strongly related to the prognosis in this study.
DISCUSSION
Management of SCC of the temporal bone remains challenging for ear and skull base surgeons due to the proximity of the dura mater and the nearby neural and vascular structures. These rare malignant tumors involve the anatomically complicated temporal bone and the lack of universally accepted cancer staging system makes treatment planning challenging. Clearly, surgery combined with or without radiotherapy is widely accepted as the standard of treatment and previous reports found that radiotherapy alone or salvage surgery after radiotherapy had depressingly poor prognoses. [1, 4, 5] However, the results of these previous studies are limited by the small number of patients involved and too long periods of time required to collect these cases. Long periods of surveillance resulted in different qualities in imaging studies used for staging and different surgical techniques. Many factors make it difficult to get clear information from the literature regarding prognosis and optional treatment of temporal bone SCC.
We report here 16 cases of primary SCC of the temporal bone within a brief surveillance period (6-years). The quality of the imaging studies was similar and the same surgeon performed all surgical procedures in this study.
The University of Pittsburgh staging system for primary SCC of the external auditory canal was proposed in 1990 as a straightforward and precise system for classifying disease before treatment. [12] It is now the most common classification system and endorsed by many reports in the literature. Although many of the previous reports concluded that early stage group (T1-2) had better survival and recurrence outcome compare to advanced stage group (T3-4), some reports failed to find statistically significant differences between these two groups. [6] In the present study, there was no statistically significant difference between these two groups. The lack of significant differences in our population was probably due to the small number of patients in the early stage group (n=5), but another possibility was due to the good prognoses of two T4 cases (No.10 and 11) with extensive (≥0.5 cm) soft tissue involvement but limited external auditory canal bony erosion, they were alive without disease. Moore et al also failed to find significant difference between early stage group (T1-2) and advanced stage group (T3-4), with the majority of their T4 cases being classified as such because of extensive soft tissue involvement. [6] Because extensive bone erosion, but not extensive soft tissue involvement, significantly correlated with a worse prognosis in this study, further investigations to elucidate a universal staging system must be continued.
The University of Pittsburgh staging system was modified in 2000 to reflect the opinion that facial nerve paralysis indicated a prognosis comparable to that of T4 disease. [1] Although this modification has not been evaluated in some other studies [2, 8] , our data confirm its utility in the present study. The prognoses of the three patients (No.14, 15 and 16) who presented with facial nerve paralysis before treatment were quite poor, and their survival times were no longer than 12 months. Our results support the accuracy of the Moody's modification [1] of the University Pittsburgh staging system for SCC of the temporal bone. In addition to the facial nerve paralysis, other three patients (No.8, 12 and 13) with bone destruction of the fallopian canal in the imaging studies before treatment also showed poor prognosis, their survival times were no longer than 28 months. These three patients underwent insufficient bone resections.
Within these three patients, two patients (Nos. 
